Skip to content

Evaluation of the protective effect of heated moisturizing therapy glasses on ocular surface damage related to video display terminals

Evaluation of the protective effect of heated moisturizing therapy glasses on ocular surface damage related to video display terminals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116828
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Interventions

Experimental group:Conducted two consecutive 2-hour VDT visual tasks, one of which was an un-intervened control, and the other was performed while wearing heated and moisturizing therapeutic glasses d

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 45 years (inclusive); 2.Best-corrected visual acuity in both eyes >= 0.8 (4.9); refractive errors requiring long-term use of glasses; 3.Participants voluntarily take part in the study, provide written informed consent, and are able to comply with the required ophthalmic examinations and questionnaire assessments;

Exclusion criteria

Exclusion criteria: 1.A history of ocular trauma or any ocular surgery, including refractive procedures; 2.Presence of active ocular disease (e.g., ocular inflammation, allergy), binocular vision dysfunction, eyelid abnormalities, or any other ocular conditions that may affect the study outcomes; 3.Current use of any topical ophthalmic medications other than artificial tears; 4.Long-term contact lens wear (average daily wearing time >= 5 hours over the past 3 months); Wore soft contact lenses within 1 week prior to screening, or wore rigid contact lenses within 1 month prior to screening; 5.Any systemic diseases, systemic medication use, or other factors that, in the investigator’s judgment, may make the participant unsuitable for this study; 6.Participants who are concurrently enrolled in any other clinical trial;

Design outcomes

Primary

MeasureTime frame
Fluorescein tear breakup time (FTBUT) and corneal fluorescein staining score;

Secondary

MeasureTime frame
Intraocular pressure (IOP);Lipid Layer Thickness (LLT);Lower tear meniscus height (LTMH);Non-invasive tear breakup time (NITBUT) and conjunctival hyperemia score;SANDE Questionnaire;Continuous Functional Visual Acuity (FVA) test;CVS-Q score;

Countries

China

Contacts

Public ContactChen Wei

Eye Hospital, Wenzhou Medical University

chenweimd@wmu.edu.cn+86 577 8839 6800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026